lifestyle.newsblaze.com

Author: SELLAS Life Sciences Group, Inc.

SELLAS Life Sciences Reports Full Year 2025 Financial Results and Provides Corporate Update

March 19, 2026
SELLAS Life Sciences to Present Preclinical Data Highlighting Potent Activity of SLS009 in AML at the 2026 AACR Conference

March 17, 2026
SELLAS Life Sciences Announces Enrollment of First Patient in Newly Diagnosed First-Line AML Trial of SLS009

March 12, 2026